Biomaterial Database

In vitro dissolution rates of aminorex dosage forms and their correlation with in vivo availability. 1969

W A Cressman, and C A Janicki, and P C Johnson, and J T Doluisio, and G A Braun

UI	MeSH Term	Description	Entries
D007700	Kinetics	The rate dynamics in chemical or physical systems.
D002247	Carbon Isotopes	Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope.	Carbon Isotope,Isotope, Carbon,Isotopes, Carbon
D003692	Delayed-Action Preparations	Dosage forms of a drug that act over a period of time by controlled-release processes or technology.	Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000661	Amphetamine	A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.	Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D001702	Biopharmaceutics	The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action.	Pharmaceutics,Pharmaceutic
D012995	Solubility	The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)	Solubilities
D013607	Tablets	Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed)	Tablet
D066298	In Vitro Techniques	Methods to study reactions or processes taking place in an artificial environment outside the living organism.	In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

W A Cressman, and C A Janicki, and P C Johnson, and J T Doluisio, and G A Braun

In vitro-in vivo correlation and dissolution studies with oral theophylline dosage forms.

February 1985, Journal of pharmaceutical sciences,

W A Cressman, and C A Janicki, and P C Johnson, and J T Doluisio, and G A Braun

The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.

January 1971, The Journal of clinical pharmacology and new drugs,

W A Cressman, and C A Janicki, and P C Johnson, and J T Doluisio, and G A Braun

In vitro and in vivo availability of spironolactone from oral dosage forms.

November 1976, Journal of pharmaceutical sciences,

W A Cressman, and C A Janicki, and P C Johnson, and J T Doluisio, and G A Braun

Comparative bioavailability of oral dosage forms of oxazepam--correlation with in vitro dissolution rate.

January 1977, Acta pharmacologica et toxicologica,

W A Cressman, and C A Janicki, and P C Johnson, and J T Doluisio, and G A Braun

Study on dissolution and absorption of four dosage forms of isosorbide mononitrate: level A in vitro-in vivo correlation.

October 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,

W A Cressman, and C A Janicki, and P C Johnson, and J T Doluisio, and G A Braun

Dissolution of drugs from solid dosage forms. II. In vitro and in vivo dissolutions.

October 1979, JPMA. The Journal of the Pakistan Medical Association,

W A Cressman, and C A Janicki, and P C Johnson, and J T Doluisio, and G A Braun

Quantitative correlation of absorption and in vitro dissolution kinetics of aspirin from several dosage forms.

May 1970, Journal of pharmaceutical sciences,

W A Cressman, and C A Janicki, and P C Johnson, and J T Doluisio, and G A Braun

"In vitro" dissolution tests for solid oral dosage forms.

September 1977, Bollettino chimico farmaceutico,

W A Cressman, and C A Janicki, and P C Johnson, and J T Doluisio, and G A Braun

In vitro-in vivo correlation from lactide-co-glycolide polymeric dosage forms.

December 2014, Progress in biomaterials,